Vaccines for cancer could be ready by 2030, according to Moderna chief

manchestereveningnews.co.uk:

There could be vaccines for a wide range of conditions - including cancer by 2030 - according to Moderna’s chief executive. The pharmaceutical firm said it is confident the jabs for cancer, cardiovascular and autoimmune diseases could be ready by the end of the decade – potentially saving “hundreds of thousands, if not millions of lives”.

Dr Paul Burton, chief medical officer of Moderna, believes the firm will be able to offer such treatments for “all sorts of disease areas” in as little as five years.

The company, which created a leading Covid vaccine, is currently developing a jab that target different tumour types. READ MORE: Footage captures moment audience member 'screams' over I Will Always Love You at Bodyguard Palace Theatre show before police show up “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives,” he told The Guardian. “I think we will be able to offer personalised cancer vaccines against multiple different tumour types to people around the world.” He added that multiple respiratory infections could be covered by a single injection, meaning vulnerable people could protected against Covid, flu and respiratory syncytial virus.

MRNA therapies could also be available for rare diseases for which there are currently no drugs. The therapies work by teaching cells how to create a protein that triggers the body’s immune response against disease. “I think we will have mRNA-based therapies for rare diseases that were previously undruggable, and I think that 10 years from now, we will be approaching a world where you truly can identify the genetic cause of a disease and, with relative simplicity, go and edit that out and repair it